Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Isophane Insulin Injection Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Isophane Insulin Injection Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Industry: Pharma & Healthcare

Published: 2023-06-05

Pages: 76 Pages

Report ld: 1347532

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Isophane Insulin Injection is used in the treatment of moderate and mild diabetes patients. Severe cases must be combined with regular insulin to reduce the number of daily insulin injections and control nighttime hyperglycemia. This drug is classified under the Diabetes and other drug categories.

Isophane Insulin Injection report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Isophane Insulin Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from People With Mild Diabetes and Patients With Severe Diabetes are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Isophane Insulin Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.
Globally, Isophane Insulin Injection key manufacturers include Ranbaxy Laboratories Ltd., Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd and Novo Nordisk Pharma lndia Ltd., etc. Ranbaxy Laboratories Ltd., Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd, Novo Nordisk Pharma lndia Ltd. are top 3 players and held % sales share in total in 2022.

Isophane Insulin Injection can be divided into 3ml/300Units and 10ml/400Units, etc. 3ml/300Units is the mainstream product in the market, accounting for % sales share globally in 2022.

Isophane Insulin Injection is widely used in various fields, such as People With Mild Diabetes and Patients With Severe Diabetes, etc. People With Mild Diabetes provides greatest supports to the Isophane Insulin Injection industry development. In 2022, global % sales of Isophane Insulin Injection went into People With Mild Diabetes filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Isophane Insulin Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Ranbaxy Laboratories Ltd.
Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd
Novo Nordisk Pharma lndia Ltd.

Segment by Type
3ml/300Units
10ml/400Units

Segment by Application
People With Mild Diabetes
Patients With Severe Diabetes

Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Each chapter of the report provides detailed information for readers to understand the Isophane Insulin Injection market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Isophane Insulin Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Isophane Insulin Injection industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Isophane Insulin Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Isophane Insulin Injection introduction, etc. Isophane Insulin Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Isophane Insulin Injection market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 Isophane Insulin Injection Market Overview
    1.1 Isophane Insulin Injection Product Overview
    1.2 Isophane Insulin Injection Market Segment by Type
        1.2.1 3ml/300Units
        1.2.2 10ml/400Units
    1.3 Global Isophane Insulin Injection Market Size by Type
        1.3.1 Global Isophane Insulin Injection Market Size Overview by Type (2018-2029)
        1.3.2 Global Isophane Insulin Injection Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Isophane Insulin Injection Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Isophane Insulin Injection Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Isophane Insulin Injection Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Isophane Insulin Injection Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Isophane Insulin Injection Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Isophane Insulin Injection Sales Breakdown by Type (2018-2023)

 2 Global Isophane Insulin Injection Market Competition by Company
    2.1 Global Top Players by Isophane Insulin Injection Sales (2018-2023)
    2.2 Global Top Players by Isophane Insulin Injection Revenue (2018-2023)
    2.3 Global Top Players by Isophane Insulin Injection Price (2018-2023)
    2.4 Global Top Manufacturers Isophane Insulin Injection Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Isophane Insulin Injection Market Competitive Situation and Trends
        2.5.1 Isophane Insulin Injection Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Isophane Insulin Injection Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Isophane Insulin Injection as of 2022)
    2.7 Date of Key Manufacturers Enter into Isophane Insulin Injection Market
    2.8 Key Manufacturers Isophane Insulin Injection Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Isophane Insulin Injection Status and Outlook by Region
    3.1 Global Isophane Insulin Injection Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Isophane Insulin Injection Historic Market Size by Region
        3.2.1 Global Isophane Insulin Injection Sales in Volume by Region (2018-2023)
        3.2.2 Global Isophane Insulin Injection Sales in Value by Region (2018-2023)
        3.2.3 Global Isophane Insulin Injection Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Isophane Insulin Injection Forecasted Market Size by Region
        3.3.1 Global Isophane Insulin Injection Sales in Volume by Region (2024-2029)
        3.3.2 Global Isophane Insulin Injection Sales in Value by Region (2024-2029)
        3.3.3 Global Isophane Insulin Injection Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Isophane Insulin Injection by Application
    4.1 Isophane Insulin Injection Market Segment by Application
        4.1.1 People With Mild Diabetes
        4.1.2 Patients With Severe Diabetes
    4.2 Global Isophane Insulin Injection Market Size by Application
        4.2.1 Global Isophane Insulin Injection Market Size Overview by Application (2018-2029)
        4.2.2 Global Isophane Insulin Injection Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Isophane Insulin Injection Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Isophane Insulin Injection Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Isophane Insulin Injection Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Isophane Insulin Injection Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Isophane Insulin Injection Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Isophane Insulin Injection Sales Breakdown by Application (2018-2023)

 5 North America Isophane Insulin Injection by Country
    5.1 North America Isophane Insulin Injection Historic Market Size by Country
        5.1.1 North America Isophane Insulin Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Isophane Insulin Injection Sales in Volume by Country (2018-2023)
        5.1.3 North America Isophane Insulin Injection Sales in Value by Country (2018-2023)
    5.2 North America Isophane Insulin Injection Forecasted Market Size by Country
        5.2.1 North America Isophane Insulin Injection Sales in Volume by Country (2024-2029)
        5.2.2 North America Isophane Insulin Injection Sales in Value by Country (2024-2029)

 6 Europe Isophane Insulin Injection by Country
    6.1 Europe Isophane Insulin Injection Historic Market Size by Country
        6.1.1 Europe Isophane Insulin Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Isophane Insulin Injection Sales in Volume by Country (2018-2023)
        6.1.3 Europe Isophane Insulin Injection Sales in Value by Country (2018-2023)
    6.2 Europe Isophane Insulin Injection Forecasted Market Size by Country
        6.2.1 Europe Isophane Insulin Injection Sales in Volume by Country (2024-2029)
        6.2.2 Europe Isophane Insulin Injection Sales in Value by Country (2024-2029)

 7 Asia-Pacific Isophane Insulin Injection by Region
    7.1 Asia-Pacific Isophane Insulin Injection Historic Market Size by Region
        7.1.1 Asia-Pacific Isophane Insulin Injection Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Isophane Insulin Injection Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Isophane Insulin Injection Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Isophane Insulin Injection Forecasted Market Size by Region
        7.2.1 Asia-Pacific Isophane Insulin Injection Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Isophane Insulin Injection Sales in Value by Region (2024-2029)

 8 Latin America Isophane Insulin Injection by Country
    8.1 Latin America Isophane Insulin Injection Historic Market Size by Country
        8.1.1 Latin America Isophane Insulin Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Isophane Insulin Injection Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Isophane Insulin Injection Sales in Value by Country (2018-2023)
    8.2 Latin America Isophane Insulin Injection Forecasted Market Size by Country
        8.2.1 Latin America Isophane Insulin Injection Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Isophane Insulin Injection Sales in Value by Country (2024-2029)

 9 Middle East and Africa Isophane Insulin Injection by Country
    9.1 Middle East and Africa Isophane Insulin Injection Historic Market Size by Country
        9.1.1 Middle East and Africa Isophane Insulin Injection Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Isophane Insulin Injection Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Isophane Insulin Injection Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Isophane Insulin Injection Forecasted Market Size by Country
        9.2.1 Middle East and Africa Isophane Insulin Injection Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Isophane Insulin Injection Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 Ranbaxy Laboratories Ltd.
        10.1.1 Ranbaxy Laboratories Ltd. Company Information
        10.1.2 Ranbaxy Laboratories Ltd. Introduction and Business Overview
        10.1.3 Ranbaxy Laboratories Ltd. Isophane Insulin Injection Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Ranbaxy Laboratories Ltd. Isophane Insulin Injection Products Offered
        10.1.5 Ranbaxy Laboratories Ltd. Recent Development
    10.2 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd
        10.2.1 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Company Information
        10.2.2 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Introduction and Business Overview
        10.2.3 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Products Offered
        10.2.5 Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Recent Development
    10.3 Novo Nordisk Pharma lndia Ltd.
        10.3.1 Novo Nordisk Pharma lndia Ltd. Company Information
        10.3.2 Novo Nordisk Pharma lndia Ltd. Introduction and Business Overview
        10.3.3 Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Products Offered
        10.3.5 Novo Nordisk Pharma lndia Ltd. Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Isophane Insulin Injection Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Isophane Insulin Injection Industrial Chain Analysis
    11.4 Isophane Insulin Injection Market Dynamics
        11.4.1 Isophane Insulin Injection Industry Trends
        11.4.2 Isophane Insulin Injection Market Drivers
        11.4.3 Isophane Insulin Injection Market Challenges
        11.4.4 Isophane Insulin Injection Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Isophane Insulin Injection Distributors
    12.3 Isophane Insulin Injection Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of 3ml/300Units
    Table 2. Major Company of 10ml/400Units
    Table 3. Global Isophane Insulin Injection Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 4. Global Isophane Insulin Injection Sales by Type (2018-2023) & (K Doses)
    Table 5. Global Isophane Insulin Injection Sales Market Share in Volume by Type (2018-2023)
    Table 6. Global Isophane Insulin Injection Sales by Type (2018-2023) & (US& Million)
    Table 7. Global Isophane Insulin Injection Market Share in Value by Type (2018-2023)
    Table 8. Global Isophane Insulin Injection Price by Type (2018-2023) & (US$/Dose)
    Table 9. Global Isophane Insulin Injection Sales by Type (2024-2029) & (K Doses)
    Table 10. Global Isophane Insulin Injection Sales Market Share in Volume by Type (2024-2029)
    Table 11. Global Isophane Insulin Injection Sales by Type (2024-2029) & (US$ Million)
    Table 12. Global Isophane Insulin Injection Sales Market Share in Value by Type (2024-2029)
    Table 13. Global Isophane Insulin Injection Price by Type (2024-2029) & (US$/Dose)
    Table 14. North America Isophane Insulin Injection Sales by Type (2018-2023) & (K Doses)
    Table 15. North America Isophane Insulin Injection Sales by Type (2018-2023) & (US$ Million)
    Table 16. Europe Isophane Insulin Injection Sales (K Doses) by Type (2018-2023)
    Table 17. Europe Isophane Insulin Injection Sales by Type (2018-2023) & (US$ Million)
    Table 18. Asia-Pacific Isophane Insulin Injection Sales (K Doses) by Type (2018-2023)
    Table 19. Asia-Pacific Isophane Insulin Injection Sales by Type (2018-2023) & (US$ Million)
    Table 20. Latin America Isophane Insulin Injection Sales (K Doses) by Type (2018-2023)
    Table 21. Latin America Isophane Insulin Injection Sales by Type (2018-2023) & (US$ Million)
    Table 22. Middle East and Africa Isophane Insulin Injection Sales (K Doses) by Type (2018-2023)
    Table 23. Middle East and Africa Isophane Insulin Injection Sales by Type (2018-2023) & (US$ Million)
    Table 24. Global Isophane Insulin Injection Sales by Company (2018-2023) & (K Doses)
    Table 25. Global Isophane Insulin Injection Sales Share by Company (2018-2023)
    Table 26. Global Isophane Insulin Injection Revenue by Company (2018-2023) & (US$ Million)
    Table 27. Global Isophane Insulin Injection Revenue Share by Company (2018-2023)
    Table 28. Global Market Isophane Insulin Injection Price by Company (2018-2023) & (US$/Dose)
    Table 29. Global Isophane Insulin Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global Isophane Insulin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Isophane Insulin Injection as of 2022)
    Table 32. Date of Key Manufacturers Enter into Isophane Insulin Injection Market
    Table 33. Key Manufacturers Isophane Insulin Injection Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Isophane Insulin Injection Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Global Isophane Insulin Injection Sales by Region (2018-2023) & (K Doses)
    Table 37. Global Isophane Insulin Injection Sales Market Share in Volume by Region (2018-2023)
    Table 38. Global Isophane Insulin Injection Sales by Region (2018-2023) & (US$ Million)
    Table 39. Global Isophane Insulin Injection Sales Market Share in Value by Region (2018-2023)
    Table 40. Global Isophane Insulin Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 41. Global Isophane Insulin Injection Sales by Region (2024-2029) & (K Doses)
    Table 42. Global Isophane Insulin Injection Sales Market Share in Volume by Region (2024-2029)
    Table 43. Global Isophane Insulin Injection Sales by Region (2024-2029) & (US$ Million)
    Table 44. Global Isophane Insulin Injection Sales Market Share in Value by Region (2024-2029)
    Table 45. Global Isophane Insulin Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2029)
    Table 46. Global Isophane Insulin Injection Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 47. Global Isophane Insulin Injection Sales by Application (2018-2023) & (K Doses)
    Table 48. Global Isophane Insulin Injection Sales Market Share in Volume by Application (2018-2023)
    Table 49. Global Isophane Insulin Injection Sales by Application (2018-2023) & (US$ Million)
    Table 50. Global Isophane Insulin Injection Sales Market Share in Value by Application (2018-2023)
    Table 51. Global Isophane Insulin Injection Price by Application (2018-2023) & (US$/Dose)
    Table 52. Global Isophane Insulin Injection Sales by Application (2024-2029) & (K Doses)
    Table 53. Global Isophane Insulin Injection Sales Market Share in Volume by Application (2024-2029)
    Table 54. Global Isophane Insulin Injection Sales by Application (2024-2029) & (US$ Million)
    Table 55. Global Isophane Insulin Injection Sales Market Share in Value by Application (2024-2029)
    Table 56. Global Isophane Insulin Injection Price by Application (2024-2029) & (US$/Dose)
    Table 57. North America Isophane Insulin Injection Sales by Application (2018-2023) (K Doses) 
    Table 58. North America Isophane Insulin Injection Sales by Application (2018-2023) & (US$ Million)
    Table 59. Europe Isophane Insulin Injection Sales by Application (2018-2023) (K Doses) 
    Table 60. Europe Isophane Insulin Injection Sales by Application (2018-2023) & (US$ Million)
    Table 61. Asia-Pacific Isophane Insulin Injection Sales by Application (2018-2023) (K Doses) 
    Table 62. Asia-Pacific Isophane Insulin Injection Sales by Application (2018-2023) & (US$ Million)
    Table 63. Latin America Isophane Insulin Injection Sales by Application (2018-2023) (K Doses) 
    Table 64. Latin America Isophane Insulin Injection Sales by Application (2018-2023) & (US$ Million)
    Table 65. Middle East and Africa Isophane Insulin Injection Sales by Application (2018-2023) (K Doses) 
    Table 66. Middle East and Africa Isophane Insulin Injection Sales by Application (2018-2023) & (US$ Million)
    Table 67. North America Isophane Insulin Injection Sales by Country (2018-2023) & (K Doses)
    Table 68. North America Isophane Insulin Injection Sales Market Share in Volume by Country (2018-2023)
    Table 69. North America Isophane Insulin Injection Sales by Country (2018-2023) & (US$ Million)
    Table 70. North America Isophane Insulin Injection Sales Market Share in Value by Country (2018-2023)
    Table 71. North America Isophane Insulin Injection Sales by Country (2024-2029) & (K Doses)
    Table 72. North America Isophane Insulin Injection Sales Market Share in Volume by Country (2024-2029)
    Table 73. North America Isophane Insulin Injection Sales by Country (2024-2029) & (US$ Million)
    Table 74. North America Isophane Insulin Injection Sales Market Share in Value by Country (2024-2029)
    Table 75. Europe Isophane Insulin Injection Sales by Country (2018-2023) & (K Doses)
    Table 76. Europe Isophane Insulin Injection Sales Market Share in Volume by Country (2018-2023)
    Table 77. Europe Isophane Insulin Injection Sales by Country (2018-2023) & (US$ Million)
    Table 78. Europe Isophane Insulin Injection Sales Market Share in Value by Country (2018-2023)
    Table 79. Europe Isophane Insulin Injection Sales by Country (2024-2029) & (K Doses)
    Table 80. Europe Isophane Insulin Injection Sales Market Share in Volume by Country (2024-2029)
    Table 81. Europe Isophane Insulin Injection Sales by Country (2024-2029) & (US$ Million)
    Table 82. Europe Isophane Insulin Injection Sales Market Share in Value by Country (2024-2029)
    Table 83. Asia-Pacific Isophane Insulin Injection Sales by Region (2018-2023) & (K Doses)
    Table 84. Asia-Pacific Isophane Insulin Injection Sales Market Share in Volume by Region (2018-2023)
    Table 85. Asia-Pacific Isophane Insulin Injection Sales by Region (2018-2023) & (US$ Million)
    Table 86. Asia-Pacific Isophane Insulin Injection Sales Market Share in Value by Region (2018-2023)
    Table 87. Asia-Pacific Isophane Insulin Injection Sales by Region (2024-2029) & (K Doses)
    Table 88. Asia-Pacific Isophane Insulin Injection Sales Market Share in Volume by Region (2024-2029)
    Table 89. Asia-Pacific Isophane Insulin Injection Sales by Region (2024-2029) & (US$ Million)
    Table 90. Asia-Pacific Isophane Insulin Injection Sales Market Share in Value by Region (2024-2029)
    Table 91. Latin America Isophane Insulin Injection Sales by Country (2018-2023) & (K Doses)
    Table 92. Latin America Isophane Insulin Injection Sales Market Share in Volume by Country (2018-2023)
    Table 93. Latin America Isophane Insulin Injection Sales by Country (2018-2023) & (US$ Million)
    Table 94. Latin America Isophane Insulin Injection Sales Market Share in Value by Country (2018-2023)
    Table 95. Latin America Isophane Insulin Injection Sales by Country (2024-2029) & (K Doses)
    Table 96. Latin America Isophane Insulin Injection Sales Market Share in Volume by Country (2024-2029)
    Table 97. Latin America Isophane Insulin Injection Sales by Country (2024-2029) & (US$ Million)
    Table 98. Latin America Isophane Insulin Injection Sales Market Share in Value by Country (2024-2029)
    Table 99. Middle East and Africa Isophane Insulin Injection Sales by Country (2018-2023) & (K Doses)
    Table 100. Middle East and Africa Isophane Insulin Injection Sales Market Share in Volume by Country (2018-2023)
    Table 101. Middle East and Africa Isophane Insulin Injection Sales by Country (2018-2023) & (US$ Million)
    Table 102. Middle East and Africa Isophane Insulin Injection Sales Market Share in Value by Country (2018-2023)
    Table 103. Middle East and Africa Isophane Insulin Injection Sales by Country (2024-2029) & (K Doses)
    Table 104. Middle East and Africa Isophane Insulin Injection Sales Market Share in Volume by Country (2024-2029)
    Table 105. Middle East and Africa Isophane Insulin Injection Sales by Country (2024-2029) & (US$ Million)
    Table 106. Middle East and Africa Isophane Insulin Injection Sales Market Share in Value by Country (2024-2029)
    Table 107. Ranbaxy Laboratories Ltd. Company Information
    Table 108. Ranbaxy Laboratories Ltd. Introduction and Business Overview
    Table 109. Ranbaxy Laboratories Ltd. Isophane Insulin Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 110. Ranbaxy Laboratories Ltd. Isophane Insulin Injection Product
    Table 111. Ranbaxy Laboratories Ltd. Recent Development
    Table 112. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Company Information
    Table 113. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Introduction and Business Overview
    Table 114. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 115. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Isophane Insulin Injection Product
    Table 116. Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd Recent Development
    Table 117. Novo Nordisk Pharma lndia Ltd. Company Information
    Table 118. Novo Nordisk Pharma lndia Ltd. Introduction and Business Overview
    Table 119. Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2023)
    Table 120. Novo Nordisk Pharma lndia Ltd. Isophane Insulin Injection Product
    Table 121. Novo Nordisk Pharma lndia Ltd. Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Isophane Insulin Injection Market Trends
    Table 125. Isophane Insulin Injection Market Drivers
    Table 126. Isophane Insulin Injection Market Challenges
    Table 127. Isophane Insulin Injection Market Restraints
    Table 128. Isophane Insulin Injection Distributors List
    Table 129. Isophane Insulin Injection Downstream Customers
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Isophane Insulin Injection Product Picture
    Figure 2. Global Isophane Insulin Injection Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Isophane Insulin Injection Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Isophane Insulin Injection Sales Status and Outlook (2018-2029) & (K Doses)
    Figure 5. Product Picture of 3ml/300Units
    Figure 6. Global 3ml/300Units Sales YoY Growth (2018-2029) & (K Doses)
    Figure 7. Product Picture of 10ml/400Units
    Figure 8. Global 10ml/400Units Sales YoY Growth (2018-2029) & (K Doses)
    Figure 9. Global Isophane Insulin Injection Sales by Type (2018-2029) & (US$ Million)
    Figure 10. Global Isophane Insulin Injection Sales Market Share by Type in 2022 & 2029
    Figure 11. North America Isophane Insulin Injection Sales Market Share in Volume by Type in 2022
    Figure 12. North America Isophane Insulin Injection Sales Market Share in Value by Type in 2022
    Figure 13. Europe Isophane Insulin Injection Sales Market Share in Volume by Type in 2022
    Figure 14. Europe Isophane Insulin Injection Sales Market Share in Value by Type in 2022
    Figure 15. Asia-Pacific Isophane Insulin Injection Sales Market Share in Volume by Type in 2022
    Figure 16. Asia-Pacific Isophane Insulin Injection Sales Market Share in Value by Type in 2022
    Figure 17. Latin America Isophane Insulin Injection Sales Market Share in Volume by Type in 2022
    Figure 18. Latin America Isophane Insulin Injection Sales Market Share in Value by Type in 2022
    Figure 19. Middle East and Africa Isophane Insulin Injection Sales Market Share in Volume by Type in 2022
    Figure 20. Middle East and Africa Isophane Insulin Injection Sales Market Share in Value by Type in 2022
    Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Isophane Insulin Injection Sales in 2022
    Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Isophane Insulin Injection Revenue in 2022
    Figure 23. Isophane Insulin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 24. Product Picture of People With Mild Diabetes
    Figure 25. Global People With Mild Diabetes Sales YoY Growth (2018-2029) & (K Doses)
    Figure 26. Product Picture of Patients With Severe Diabetes
    Figure 27. Global Patients With Severe Diabetes Sales YoY Growth (2018-2029) & (K Doses)
    Figure 28. Global Isophane Insulin Injection Sales by Application (2018-2029) & (US$ Million)
    Figure 29. Global Isophane Insulin Injection Sales Market Share by Application in 2022 & 2029
    Figure 30. North America Isophane Insulin Injection Sales Market Share in Volume by Application in 2022
    Figure 31. North America Isophane Insulin Injection Sales Market Share in Value by Application in 2022
    Figure 32. Europe Isophane Insulin Injection Sales Market Share in Volume by Application in 2022
    Figure 33. Europe Isophane Insulin Injection Sales Market Share in Value by Application in 2022
    Figure 34. Asia-Pacific Isophane Insulin Injection Sales Market Share in Volume by Application in 2022
    Figure 35. Asia-Pacific Isophane Insulin Injection Sales Market Share in Value by Application in 2022
    Figure 36. Latin America Isophane Insulin Injection Sales Market Share in Volume by Application in 2022
    Figure 37. Latin America Isophane Insulin Injection Sales Market Share in Value by Application in 2022
    Figure 38. Middle East and Africa Isophane Insulin Injection Sales Market Share in Value by Application in 2022
    Figure 39. Key Raw Materials Price
    Figure 40. Isophane Insulin Injection Manufacturing Cost Structure
    Figure 41. Isophane Insulin Injection Industrial Chain Analysis
    Figure 42. Channels of Distribution
    Figure 43. Distributors Profiles
    Figure 44. Bottom-up and Top-down Approaches for This Report
    Figure 45. Data Triangulation
    Figure 46. Key Executives Interviewed

Isophane Insulin Injection is used in the treatment of moderate and mild diabetes patients. Severe cases must be combined with regular insulin to reduce the number of daily insulin injections and control nighttime hyperglycemia. This drug is classified under the Diabetes and other drug categories.

Isophane Insulin Injection report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Isophane Insulin Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from People With Mild Diabetes and Patients With Severe Diabetes are the major drivers for the industry.

Isophane Insulin Injection can be divided into 3ml/300Units and 10ml/400Units, etc. 3ml/300Units is the mainstream product in the market, accounting for % sales share globally in 2022.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Ranbaxy Laboratories Ltd.
Jiangsu Wanbang Biochemical and Pharmaceutical Co. Ltd
Novo Nordisk Pharma lndia Ltd.

Segment by Type
3ml/300Units
10ml/400Units

Segment by Application
People With Mild Diabetes
Patients With Severe Diabetes

Industry: Pharma & Healthcare

Published: 2023-06-05

Pages: 76 Pages

Report ld: 1347532

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License